Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Brainstorm Cell (NQ: BCLI )

1.520 -0.020 (-1.30%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 152,546
Open 1.560
Bid (Size) 1.500 (2)
Ask (Size) 1.600 (1)
Prev. Close 1.540
Today's Range 1.490 - 1.570
52wk Range 1.085 - 4.700
Shares Outstanding 36,541,779
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
BioRestorative Therapies Inc. (NASDAQ: BRTX) (“BioRestorative”) may have had a successful year of novel drug development. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday morning! 
Via InvestorPlace

Performance

YTD
-8.98%
-8.98%
1 Month
+6.29%
+6.29%
3 Month
-55.43%
-55.43%
6 Month
-40.62%
-40.62%
1 Year
-48.30%
-48.30%

More News

Read More
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
BrainStorm To File US Application For NurOwn In Amyotrophic Lateral Sclerosis
Via Benzinga
Recap: Brainstorm Cell Q1 Earnings
Via Benzinga
Earnings Scheduled For May 16, 2022
Via Benzinga
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
Via Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Via Benzinga
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
FDA Refuses To Accept BrainStorm Cell's Lead Candidate For Amyotrophic Lateral Sclerosis
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field
Via TheNewswire.com
A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field
Via News Direct
A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field
Via Benzinga
Recap: Brainstorm Cell Q2 Earnings
Via Benzinga
Earnings Scheduled For August 15, 2022
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine
Via Benzinga
Brainstorm Cell Earnings Preview
Via Benzinga
Brainstorm Cell: Q4 Earnings Insights
Via Benzinga
Earnings Scheduled For March 28, 2022
Via Benzinga
Preview: Brainstorm Cell's Earnings
Via Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.